Extended-hours hemodialysis is associated with lower mortality risk in patients with end-stage renal disease.
暂无分享,去创建一个
A. Cheung | K. Kalantar-Zadeh | R. Katz | J. Himmelfarb | Sooraj KuttyKrishnan | O. Arah | R. Mehrotra | M. Molnar | S. Adams | Vanessa A. Ravel | M. Soohoo | E. Streja | Matthew B. Rivara
[1] G. Beck,et al. Long-Term Effects of Frequent In-Center Hemodialysis. , 2016, Journal of the American Society of Nephrology : JASN.
[2] Christopher T. Chan,et al. Long-term Effects of Frequent Nocturnal Hemodialysis on Mortality: The Frequent Hemodialysis Network (FHN) Nocturnal Trial. , 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[3] A. Cheung,et al. Predictors of treatment with dialysis modalities in observational studies for comparative effectiveness research. , 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[4] Christopher T. Chan,et al. Design and participant baseline characteristics of ‘A Clinical Trial of IntensiVE Dialysis’: The ACTIVE Dialysis Study , 2015, Nephrology.
[5] B. Kestenbaum,et al. Uncorrected and Albumin-Corrected Calcium, Phosphorus, and Mortality in Patients Undergoing Maintenance Dialysis. , 2015, Journal of the American Society of Nephrology : JASN.
[6] P. Gustafson,et al. Practice of Epidemiology Marginal Structural Cox Models for Estimating the Association Between β-Interferon Exposure and Disease Progression in a Multiple Sclerosis Cohort , 2014 .
[7] P. Cummings. Missing data and multiple imputation. , 2013, JAMA pediatrics.
[8] P. Kerr,et al. Longer dialysis session length is associated with better intermediate outcomes and survival among patients on in-center three times per week hemodialysis: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[9] G. Curhan,et al. Shorter length dialysis sessions are associated with increased mortality, independent of body weight , 2012, Kidney international.
[10] Christopher T. Chan,et al. Impact of Frequent Nocturnal Hemodialysis on Myocardial Mechanics and Cardiomyocyte Gene Expression , 2012, Circulation. Cardiovascular imaging.
[11] P. Eggers,et al. Challenges to enrollment and randomization of the Frequent Hemodialysis Network (FHN) Daily Trial. , 2012, Journal of nephrology.
[12] A. Garg,et al. Survival with three-times weekly in-center nocturnal versus conventional hemodialysis. , 2012, Journal of the American Society of Nephrology : JASN.
[13] Christopher T. Chan,et al. Intensive hemodialysis associates with improved survival compared with conventional hemodialysis. , 2012, Journal of the American Society of Nephrology : JASN.
[14] P. McFarlane,et al. Regression of left ventricular mass following conversion from conventional hemodialysis to thrice weekly in-centre nocturnal hemodialysis , 2012, BMC Nephrology.
[15] Christopher T. Chan,et al. The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. , 2011, Kidney international.
[16] E. Ok,et al. Comparison of 4- and 8-h dialysis sessions in thrice-weekly in-centre haemodialysis: a prospective, case-controlled study. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[17] Stephen E Kimmel,et al. Rapid fluid removal during dialysis is associated with cardiovascular morbidity and mortality. , 2011, Kidney international.
[18] G. Beck,et al. In-center hemodialysis six times per week versus three times per week. , 2010, The New England journal of medicine.
[19] G. Chertow,et al. Shorter dialysis times are associated with higher mortality among incident hemodialysis patients. , 2010, Kidney international.
[20] R. Hakim,et al. Outcomes associated with in-center nocturnal hemodialysis from a large multicenter program. , 2010, Clinical journal of the American Society of Nephrology : CJASN.
[21] Yijian Huang,et al. Survival and hospitalization among patients using nocturnal and short daily compared to conventional hemodialysis: a USRDS study. , 2009, Kidney international.
[22] A. Jardine,et al. Ten years experience of in-center thrice weekly long overnight hemodialysis. , 2009, Clinical journal of the American Society of Nephrology : CJASN.
[23] Samy Suissa,et al. Immortal time bias in pharmaco-epidemiology. , 2008, American journal of epidemiology.
[24] S. Pocock,et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. , 2007, Preventive medicine.
[25] M. Tonelli,et al. Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial. , 2007, JAMA.
[26] P. Kerr,et al. Associations of hemodialysis dose and session length with mortality risk in Australian and New Zealand patients. , 2006, Kidney international.
[27] J. Bragg-Gresham,et al. Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS. , 2006, Kidney international.
[28] M. Tonelli,et al. A systematic review of the effect of nocturnal hemodialysis on blood pressure, left ventricular hypertrophy, anemia, mineral metabolism, and health-related quality of life. , 2005, Kidney international.
[29] P. Bossuyt,et al. Effect of starting with hemodialysis compared with peritoneal dialysis in patients new on dialysis treatment: a randomized controlled trial. , 2003, Kidney international.
[30] Francesco Locatelli,et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. , 2003, The New England journal of medicine.
[31] Christopher T. Chan,et al. Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis. , 2002, Kidney international.
[32] S. Cole,et al. Use of a marginal structural model to determine the effect of aspirin on cardiovascular mortality in the Physicians' Health Study. , 2002, American journal of epidemiology.
[33] J. Robins,et al. Marginal Structural Models and Causal Inference in Epidemiology , 2000, Epidemiology.
[34] J. Robins,et al. Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. , 2000, Epidemiology.
[35] R Francoeur,et al. Control of serum phosphate without any phosphate binders in patients treated with nocturnal hemodialysis. , 1998, Kidney international.
[36] R M Hakim,et al. Effects of dose of dialysis on morbidity and mortality. , 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[37] S. Greenland,et al. Association of hemodialysis treatment time and dose with mortality and the role of race and sex. , 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[38] R. Cicerone. Initial National Priorities for Comparative Effectiveness Research , 2009 .
[39] C. Chan,et al. Reduction in cardiovascular related hospitalization with nocturnal home hemodialysis. , 2008, Clinical nephrology.